Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

26.09
-0.1900-0.72%
Pre-market: 26.00-0.0900-0.34%04:01 EDT
Volume:2.65M
Turnover:68.33M
Market Cap:4.17B
PE:-63.43
High:26.14
Open:26.00
Low:25.12
Close:26.28
52wk High:30.74
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.97
T/O Rate:2.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:29.17
PE(LYR):-66.53

Loading ...

BUZZ-Adaptive Biotechnologies up after boosted $300 mln convertible bond sale

Reuters
·
Jun 17

Adaptive Biotechnologies prices upsized USD 300 million 0% convertible senior notes offering due 2031

Reuters
·
Jun 17

Adaptive Biotechnologies - Prices $300 Mln 0% Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 17

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

GlobeNewswire
·
Jun 17

MRD Spinoff And $250 Million Convertible Notes Could Be A Game Changer For Adaptive Biotechnologies (ADPT)

Simply Wall St.
·
Jun 17

Analysts Are Bullish on Top Healthcare Stocks: Pasithea Therapeutics Corp (KTTA), Adaptive Biotechnologies (ADPT)

TIPRANKS
·
Jun 16

Adaptive Biotechnologies offers to sell $250M in 2031 convertible senior notes

TIPRANKS
·
Jun 16

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 common shares for $95,000

Reuters
·
Jun 16

Stocks to Watch: Dave & Buster's, Adaptive Biotechnologies, Domo, Apollo Commercial Real Estate Finance

Dow Jones
·
Jun 16

BRIEF-Adaptive Biotechnologies Announces Proposed Convertible Senior Notes Offering

Reuters
·
Jun 16

Adaptive Biotechnologies Evaluates Strategic Alternatives for Immune Medicine Business

Dow Jones
·
Jun 16

Adaptive Biotechnologies Weighs Separation of Immune Medicine Unit; Shares Fall After Hours

MT Newswires Live
·
Jun 16

BUZZ-Adaptive Biotechnologies falls after announcing convertible, separation of businesses

Reuters
·
Jun 16

Adaptive to plans to separate minimal residual disease, immune medicine segments

TIPRANKS
·
Jun 16

Adaptive Biotechnologies plans separation of MRD, Immune Medicine units

Reuters
·
Jun 16

Adaptive Biotechnologies - Expects to Identify Immune Medicine Separation Path by Year-End 2026

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies Announces Plan to Separate Its Mrd and Immune Medicine Businesses

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies plans USD 250 million convertible senior notes offering due 2031

Reuters
·
Jun 16

Adaptive Biotechnologies - to Offer $250 Mln Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies - Proceeds to Fund Capped Call and Repurchase up to $25 Mln Common Stock

THOMSON REUTERS
·
Jun 16